Overview

Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of s-adenosyl-l-methionine (SAMe) in treating major depression.
Phase:
N/A
Details
Lead Sponsor:
Maurizio Fava, MD
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)
Treatments:
Citalopram
Dexetimide